Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$341M |
| 2 |
Automatic Data Processing
ADP
|
+$325M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$248M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$195M |
| 5 |
Comcast
CMCSA
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.83B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.41B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$435M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$256M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.66% |
| 2 | Technology | 4.22% |
| 3 | Healthcare | 2.96% |
| 4 | Consumer Discretionary | 2.91% |
| 5 | Industrials | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
CAE Inc. Common Shares
CAE
$8.36B
| $1.51M | ﹤0.01% |
81,235
-836
| -1% | -$14.8K |
|
2902
Neurocrine Biosciences
NBIX
$16.7B
| $1.51M | ﹤0.01% |
19,512
-20,673
| -51% | -$1.41M |
|
|
XEC
2903
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $1.51M | ﹤0.01% |
12,400
-5,500
| -31% | -$641K |
|
2904
Dick's Sporting Goods
DKS
$17.6B
| $1.51M | ﹤0.01% |
52,561
-107,355
| -67% | -$2.96M |
|
2905
Hewlett Packard
HPE
$63.8B
| $1.51M | ﹤0.01% |
105,158
-939,760
| -90% | -$13.4M |
|
2906
ONE Gas
OGS
$4.86B
| $1.51M | ﹤0.01% |
20,582
+7,618
| +59% | +$578K |
|
2907
Pultegroup
PHM
$24.2B
| $1.5M | ﹤0.01% |
45,245
-52,042
| -53% | -$1.62M |
|
2908
PUT
Cameco
CCJ
$38.1B
| $1.5M | ﹤0.01% |
162,200
-13,200
| -8% | -$124K |
|
|
KF
2909
Korea Fund
KF
$234M
| $1.5M | ﹤0.01% |
36,240
-18,716
| -34% | -$805K |
|
2910
PUT
Macerich
MAC
$7.29B
| $1.49M | ﹤0.01% |
22,700
+21,200
| +1,413% | +$1.3M |
|
|
CAVM
2911
PUT
DELISTED
Cavium, Inc.
CAVM
| $1.48M | ﹤0.01% |
17,700
+5,300
| +43% | +$410K |
|
2912
Nutanix
NTNX
$16B
| $1.48M | ﹤0.01% |
42,021
+31,742
| +309% | +$962K |
|
2913
Portland General Electric
POR
$5.68B
| $1.48M | ﹤0.01% |
32,499
+12,812
| +65% | +$607K |
|
2914
CALL
Banco Santander
SAN
$201B
| $1.48M | ﹤0.01% |
236,348
-113,530
| -32% | -$717K |
|
2915
PUT
Barclays
BCS
$92.9B
| $1.48M | ﹤0.01% |
141,837
-2,510
| -2% | -$24.4K |
|
|
LL
2916
CALL
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.48M | ﹤0.01% |
47,100
+11,500
| +32% | +$364K |
|
|
GOOS
2917
PUT
Canada Goose Holdings
GOOS
$876M
| $1.48M | ﹤0.01% |
46,600
+6,500
| +16% | +$160K |
|
|
NBIS
2918
CALL
Nebius Group N.V.
NBIS
$48.4B
| $1.47M | ﹤0.01% |
45,000
+24,200
| +116% | +$790K |
|
2919
Matsons
MATX
$6.15B
| $1.47M | ﹤0.01% |
49,366
+7,382
| +18% | +$208K |
|
2920
PUT
Louisiana-Pacific
LPX
$5.06B
| $1.47M | ﹤0.01% |
56,000
+40,100
| +252% | +$1.09M |
|
2921
PUT
Twilio
TWLO
$29.7B
| $1.47M | ﹤0.01% |
62,300
+5,400
| +9% | +$152K |
|
2922
Hyatt Hotels
H
$16.3B
| $1.46M | ﹤0.01% |
19,890
-70,042
| -78% | -$4.74M |
|
2923
AAR Corp
AIR
$5.63B
| $1.46M | ﹤0.01% |
37,230
-6,513
| -15% | -$262K |
|
|
CLVS
2924
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.46M | ﹤0.01% |
21,500
+1,400
| +7% | +$97.9K |
|
|
NVO
2925
PUT
Novo Nordisk
NVO
$208B
| $1.46M | ﹤0.01% |
54,400
-5,400
| -9% | -$137K |
|
Similar funds
Citigroup's Q4 2017 Portfolio in Review
As of Q4 2017, Citigroup held 7,845 positions worth $125B, up 2.1% from $122B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Citigroup withdrew a net $3.77B in Q4 2017, closing 246 positions and reducing 2,883 holdings. Its most notable exit was CR Bard Inc., an estimated $210M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, up from 4.4% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Citigroup opened a new position in Global X US Preferred ETF worth $19.9M.
- Citigroup's largest Q4 2017 buy was Global X US Preferred ETF: 800,000 shares worth $19.9M.
- Citigroup added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2017, an estimated $341M increase.
- Citigroup's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.83B.
- Citigroup fully exited CR Bard Inc. in Q4 2017, selling an estimated $210M.
- Citigroup's ten largest holdings make up 26% of its $125B portfolio in Q4 2017.
- Citigroup opened 463 new positions and closed 246 in Q4 2017.
- Citigroup's portfolio value rose 2.1% quarter-over-quarter to $125B.
Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.